Use of autologous blood as part of the perfusate for cardiopulmonary bypass: A priming technique

Perfusion

Volumn 17, Issue 3, 2002, Pages 211-216

  Myers, Gerard J ^a   Legare, J F ^a   Sullivan, J A ^a   Leadon, R B ^a   Johnstone, R ^a   Swyer, W ^a   Squires, C ^a   Power, C ^a   Hirsch, G M ^a  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; NORMOSOL; PROTEIN; SERUM ALBUMIN;

ADULT; ARTICLE; BLOOD AUTOTRANSFUSION; CARDIOPULMONARY BYPASS; CELL PROTECTION; CLINICAL PROTOCOL; CONTROLLED STUDY; CRYSTALLOID; FEMALE; FLUID SHIFT; FLUID THERAPY; HOSPITALIZATION; HUMAN; INCIDENCE; INTRAOPERATIVE PERIOD; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONCOTIC PRESSURE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; BLOOD PROTEINS; BLOOD TRANSFUSION, AUTOLOGOUS; CARDIOPULMONARY BYPASS; FEMALE; FLUID THERAPY; HEPARIN; HUMANS; ISOTONIC SOLUTIONS; MALE; MIDDLE AGED; OSMOTIC PRESSURE; PERFUSION; PLASMA SUBSTITUTES; PLATELET COUNT; REHYDRATION SOLUTIONS; SERUM ALBUMIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036255282     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659102pf573oa     Document Type: Article

References (28)

1. Prevention of platelet adhesion to extracorporeal surfaces
2. Study on the prevention of surface induced platelet activation by albumin coating
3. Protein-platelet interaction on heparinized surfaces
4. Albumin immobilized poly-urethane and its blood compatibility
5. Estimation of colloid osmotic pressure during hemodilutional cardiopulmonary bypass
6. An evaluation of three methods for determining colloid osmotic pressure
7. The influence of the nature of the prime on postperfusion pulmonary changes
8. The effects of cardiopulmonary bypass with crystalloid and colloid hemodilution on myocardial extravascular water
9. Creutzfeldt-Jakob disease in the United States, 1979-1984: Using national mortality data to assess the possible occurrence of variant cases
10. A comparative review of crystalloid, albumin, Pentastarch and Hetastarch as perfusates for cardiopulmonary bypass
11. A survey of priming solutions used for cardiopulmonary bypass
12. Priming solutions for cardiopulmonary bypass: Comparison of three colloids
13. Reduction of compliment activation during bypass by prime manipulation
14. Oxygenator thrombosis: An international phenomenon
15. An update on perfusate compositions
16. Albumin in the cardiopulmonary bypass prime: How little is enough?
17. The safety and efficacy of 10% Pentastarch as a cardiopulmonary bypass priming solution
18. A prospective randomized study of hydroxyethyl starch, albumin and lactated ringers solution as a priming fluid for CPB
19. Pathological fibrin formation and cold induced clotting of membrane oxygenators during cardiopulmonary bypass
20. Heparin coated equipment reduces the risk of oxygenator failure
21. Intraoperative hetastarch infusion impairs hemostasis after cardiac operations
22. Decreased plasma albumin concentration results in increased volume distribution and decreased elimination of midazolam in intensive care patients
23. Disease induced alterations in plasma drug binding proteins and the influence on drug binding percentages in dogs
24. Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels
25. Coating of extracorporeal circuit with heparin does not prevent sequestration of propofol in vitro
26. Binding of propofol to blood components: Implications for pharmacokinetics and for pharmacodynamics
27. Propofol binding to human blood proteins
28. Does propofol alter gas exchange in membrane oxygenators